Mal-(CH2)5-Val-Cit-PAB-Eribulin T39579

Product Introduction
Bioactivity


英文名: Mal-(CH2)5-Val-Cit-PAB-Eribulin

描述: Mal-(CH2)5-Val-Cit-PAB-Eribulin is a potent antitumor ADC drug-linker conjugate that utilizes Eribulin, an anti-microtubule agent, connected through the Mal-(CH2)5-Val-Cit-PAB linker.

体外活性: Eribulin (E7389) is a microtubule targeting agent that is used for the research of metastatic breast cancer. Eribulin inhibits the proliferation of cancer cells by binding microtubule proteins and microtubules[2].

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

关键字: Mal(CH2)5ValCitPABEribulin | Mal-(CH-2)5-Val-Cit-PAB-Eribulin | Mal (CH2)5 Val Cit PAB Eribulin

Mal-(CH2)5-Val-Cit-PAB-Eribulin T39579信息由TargetMol中国为您提供，如您想了解更多关于Mal-(CH2)5-Val-Cit-PAB-Eribulin T39579报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途